L
Luis A. Rodriguez
Researcher at University of California, San Francisco
Publications - 32
Citations - 1079
Luis A. Rodriguez is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Population & Extracellular. The author has an hindex of 17, co-authored 30 publications receiving 969 citations. Previous affiliations of Luis A. Rodriguez include University of California, Berkeley.
Papers
More filters
Journal ArticleDOI
Prognostic implications of the proliferative potential of low-grade astrocytomas.
Takao Hoshino,Luis A. Rodriguez,Kyung G. Cho,Kyu S ung Lee,Charles B. Wilson,Michael S. B. Edwards,Victor A. Levin,Richard L. Davis +7 more
TL;DR: The results show that the proliferative potential, as reflected by the BUdR LI, is an important prognostic factor that separates low-grade astrocytomas into two groups and provides a more scientific rationale for selecting treatment for individual patients.
Journal ArticleDOI
Management of Hypothalamic Gliomas in Children: An Analysis of 33 Cases
TL;DR: The cases of 33 children with hypothalamic-chiasmatic gliomas are reviewed, and patients with neurofibromatosis had a better prognosis than other children with the condition.
Journal ArticleDOI
Health and economic benefits of reducing sugar intake in the USA, including effects via non-alcoholic fatty liver disease: a microsimulation model.
Rick A Vreman,Alex J. Goodell,Luis A. Rodriguez,Travis C. Porco,Travis C. Porco,Robert H. Lustig,James G. Kahn +6 more
TL;DR: The model suggests that efforts to reduce consumption of added sugars may result in significant public health and economic benefits and averted costs and DALYs were higher, mainly due to inclusion of NAFLD and CHD.
Journal ArticleDOI
Complex formation with the Type B gamma-aminobutyric acid receptor affects the expression and signal transduction of the extracellular calcium-sensing receptor. Studies with HEK-293 cells and neurons.
Wenhan Chang,Chia-Ling Tu,Zhiqiang Cheng,Luis A. Rodriguez,Tsui-Hua Chen,Martin Gassmann,Bernhard Bettler,Marta Margeta,Lily Yeh Jan,Dolores M. Shoback +9 more
TL;DR: CaRs and GABA-B-R subunits can form heteromeric complexes in cells, and their interactions affect cell surface expression and signaling of CaR, which may contribute to extracellular Ca2+-dependent receptor activation in target tissues.
Journal ArticleDOI
Reevaluation of procarbazine for the treatment of recurrent malignant central nervous system tumors.
TL;DR: Ninety‐nine patients with primary recurrent malignant tumors of the central nervous system were treated with procarbazine as a single agent, and the results are inferior to those reported previously for patients treated with Procarbazine at recurrence.